Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Patent
1996-07-19
1999-11-30
Huff, Sheila
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
514 12, 530308, 530324, 435 711, 435325, 435 691, C07K 500
Patent
active
059945001
ABSTRACT:
Antagonists of glucagon-like peptide 2, have been identified. Their effects on the growth of gastrointestinal tissue are described. Its formulation as a pharmaceutical, and its therapeutic and related uses in treating bowel tissue, are described. Also described are methods of identifying antagonists of glucagon-like peptide 2.
REFERENCES:
Barragan, J.M.; Rodriguez, R.E.; and Blazquez, E. Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36)amide in rats. American Journal of Physiology. 266 (3 Pt 1), pE459-66, Mar. 1994.
Bloom, S.R. Gut Hormones in adaptation. Gut. 28, S1, pp. 31-35, 1987.
Brubaker, Patricia L. Regulation of Intestinal Proglucagon-Derived Peptide Secretion by Intestinal Regulatory Peptides. Endocrinology. vol. 128, No. 6, pp. 3175-3182, 1991.
Buhl, Thora; Thim, Lars; Kofod, Hans; Orskov, Catherine; Harling, Henrik; and Holst, Jens J. Naturally Occurring Products of Proglucagon 111-160 in the Porcine and Human Small Intestine. The Journal of Biological Chemistry. vol. 263, No. 18, pp. 8621-8624, Issue of Jun. 25, 1988.
Calvo, J.C.; Yusta, B; Mora, F; and Blazquez, E. Structural characterization by affinity cross-linking of glucagon-like peptide-1 (7-36) amide receptor in rat brain. J. Neurochem. 64(1), pp. 299-306, Jan. 1995.
Cheeseman, Chris I.; and Raymand Tsang. The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal basolateral membrane hexose transport. The American Physiological Society. APSracts 3:0071G, Apr. 16, 1996.
Drucker, Pancreas. 1990, 5(4):484.
Ehrlich, Peter; Tucker, Devin; Asa, Sylvia L.; Brubacker, Patricia L.; and Drucker, Daniel J. Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors. American Journal of Physiology. pp. E662-E671, 1994.
Goerge, S.K.; Uttenthal, L.O.; Ghiglione, M.; and Bloom, S.R. Molecular forms of glucagon-like peptides in man. FEBS Letters. vol. 192, No. 2, pp. 275-278, Nov. 1985.
Hoosein, Naseema M.; and Gurnd, Ruth S. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Letters. vol. 178, No. 1, pp. 83-86, Dec. 1984.
Irwin, David M.; and Wong, Jaffe. Trout and Chicken Proglucagon: Alternative Splicing Generates mRNA Transcripts Encoding Glucagon-Like Peptide 2. Molecular Endocrinology. 9:267-277, 1995.
Lee, Ying C.; Asa, Sylvia L.; and Drucker, Daniel J. Glucagon Gene 5'-Flanking Sequences Direct Expression of Simian Virus 40 Large T Antigen to the Intestine, Producing Carcimona of the Large Bowel in Transgenic Mice. The Journal of Biological Chemistry. vol. 267, No. 15, pp. 10706-10708, May 25, 1992.
Lund, P. Kay; Hoyt, Eileen; Simmons, James G.; and Ulshen, Martin H. Regulation of Intestinal Glucagon Gene Expression during Adaptive Growth of Small Intestine. Digestion. 54:371-373. 1993.
Mojsov, Svetlana; Heinrich, Gerhard; Wilson, Ira B.; Ravazzola, Mariella; Orci, Lelio; and Habener, Joel F. Preproglucagon Gene Expression in Pancreas and Intestine Diversifies at the Level of Post-translational Processing. The Journal of Biological Chemistry, vol. 261, No. 25, pp. 11880--11889, Sep. 5, 1986.
Mommsen, Thomas P.; Andrews, P.C.; and Plisetskaya, Erika M. Glucagon-like peptides activate hepatic gluconeogenesis. FEBS Letters. vol. 219, No. 1, pp. 227-232, Jul. 1987.
Nishi and Steiner, Mol. Endocrinol., 1990, 4:1192-8.
Orskov, C.; Buhl, T.; Rabenhoj, L.; Kofod, H.; and Holst, J.J.. Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine. FEBS Letters. 247(2), pp. 193-196, Apr. 24, 1989.
Orskov, C.; Holst, J.J.; Pouisen, S. Seier; and Krikegaard, P. Pancreatic and intestinal processing proglucagon in man. Diabetologia. 30:874-881, 1987.
Orskov, C; and Holst, J.J. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2), Scand. J. Clin. Lab. Invest. 47(2), pp. 165-174, Apr. 1987.
Orskov, Catherine; Holst, Jens J.; Knuhtsen, Svend; Baldissera, Furio G.A.; Poulsen, Steen S.; and Nielsen, O. Vagn. Glucagon-Like Peptides GLP-1 and GLP-2. Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas. Endocrinology. vol. 119, No. 4, pp. 1467-1475, 1986.
Ruiz-Grand, C.; Pintado, J.; Alarcon, C.; Castilla, C.; Valverde, I; Lopez-Novoa, J.M. Renal catabolism of human glucagon-like peptides 1 and 2. Can. J. Physiol. Pharmacol. 68 (12), pp. 1568-1573, Dec. 1990.
Shennan, K.I.J.; Holst, J.J.; and Docherty, K. Proglucagon expression, posttranslational processing and secretion in SV40-transformed islet cells. Molecular and Cellular Endocrinology. 67(1989), pp. 93-99.
Watanabe, Nobuaki; Matsuyama, Tatsuo; Namba, Mitsuyoshi; Miyagawa, Jun-ichiro; Itoh, Hidehiko; Komatsu, Ryoya; Kono, Norio; and Tarui, Seiichiro. Trophic Effect of Glucagon-(1-21)-Peptide on the Isolated Rat Ileal Mucosal Cells. Biochemical and Biophysical Research Communications. vol. 152, No.3, pp. 1038-1044, May 16, 1988.
Crivici Anna E.
Drucker Daniel J.
Sumner-Smith Martin
1149336 Ontario Inc.
Huff Sheila
LandOfFree
Antagonists of intestinotrophic GLP-2 peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonists of intestinotrophic GLP-2 peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonists of intestinotrophic GLP-2 peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1674095